0001567619-19-016171.txt : 20190809
0001567619-19-016171.hdr.sgml : 20190809
20190809170435
ACCESSION NUMBER: 0001567619-19-016171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190808
FILED AS OF DATE: 20190809
DATE AS OF CHANGE: 20190809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAZELSKY JAY
CENTRAL INDEX KEY: 0001556270
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 191013680
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2019-08-08
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001556270
MAZELSKY JAY
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Interim President & CEO
Common Stock
2019-08-08
4
M
0
2204
45.84
A
25474
D
Common Stock
2019-08-08
4
M
0
2848
47.53
A
28322
D
Common Stock
2019-08-08
4
M
0
6306
47.53
A
34628
D
Non-Qualified Stock Option (right-to-buy)
45.84
2019-08-08
4
M
0
2204
D
2020-02-13
Common Stock
2204
13824
D
Non-Qualified Stock Option (right-to-buy)
47.53
2019-08-08
4
M
0
2848
D
2019-08-31
Common Stock
2848
0
D
Incentive Stock Option (right-to-buy)
47.53
2019-08-08
4
M
0
6306
D
2019-08-31
Common Stock
6306
0
D
Grant of option to buy 13,014 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2014 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 1,424 shares of Issuer common stock that became exercisable in five annual installments beginning September 1, 2013 without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 5,255 shares of Issuer common stock that became exercisable in five annual installments beginning September 1, 2013 without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jay Mazelsky
2019-08-09